Antipyretic Analgesics Medicines Indomethacin Capsules 25mg

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, GMP, ISO 13485, FSC
Import & Export Mode
Have Own Export License
  • Antipyretic Analgesics Medicines Indomethacin Capsules 25mg
  • Antipyretic Analgesics Medicines Indomethacin Capsules 25mg
  • Antipyretic Analgesics Medicines Indomethacin Capsules 25mg
  • Antipyretic Analgesics Medicines Indomethacin Capsules 25mg
  • Antipyretic Analgesics Medicines Indomethacin Capsules 25mg
  • Antipyretic Analgesics Medicines Indomethacin Capsules 25mg
Find Similar Products

Basic Info.

Model NO.
AMC11007-01
State
Solid
Shape
Capsules
Type
Western Medicines
Pharmaceutical Technology
Bp, USP or Cp
Shelf Life
3 Years
Registration Dossiers
Available
Standard Available
USP,Bp, Cp
Transport Package
25mg, 10X10caps. /Box
Specification
GMP
Trademark
MEDIPHARM/OEM
Origin
China
HS Code
3004909099
Production Capacity
10000ctns Per Month

Product Description

Product Description

Antipyretic Analgesics Medicines Indomethacin Capsules 25mg

Indications:

The treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, acute musculoskeletal disorders and acute gout.

Contra-indications:

Active peptic ulcer or a history of recurrent gastro-intestinal lesions. Sensitivity to aspirin, indometacin or other non-steroidal anti-inflammatory agents.

Pregnancy or lactation.

Patients operating machinery.

Patients with epilepsy, parkinsonism, psychiatric disturbances or porphyria.

Children, since conditions for safe use have not been established.

Severe heart failure.

Adverse Effects:

Most adverse effects are dose related

Gastro-intestinal adverse effects are common and include anorexia, nausea (with or without vomiting) dyspepsia, abdominal pain and diarrhoea. Infrequently, ulceration of the upper GI tract, sometimes with perforation and haemorrhage, has occurred. Acute pancreatitis has been reported. Hepatic involvement is rare, though fatal cases of hepatitis and jaundice have been reported.

CNS effects are also common. Severe frontal headache may occur in 25 - 50% of patients who take the drug chronically. Dizziness, light-headedness, vertigo and mental confusion are also frequent. Depression and psychosis have also been reported but the incidence is less than 1%.

Haemopoietic reactions, including neutropenia, thrombocytopenia and, rarely, aplastic anaemia have been reported.

Hypersensitivity reactions, manifested as rashes, itching, urticaria or rarely acute asthma, may occur.

Oedema, hypertension, and cardiac failure, have been reported in association with NSAID treatment.
 

Testing terms Standards Results
definition indometacin capsule includes Indometacin indometacin capsule includes Indometacin
Related substance up to standard up to standard
Dissolution Q≥80% up to standard
Package differencial up to standard up to standard
Microbial limit bacterial   count≤1000cfu/g
fungal and yeast count≤100cfu/g
No Escherichia coli
up to standard
up to standard
up to standard
Assay 90.0%-110.0% 99.2%
Antipyretic Analgesics Medicines Indomethacin Capsules 25mgAntipyretic Analgesics Medicines Indomethacin Capsules 25mg

Antipyretic Analgesics Medicines Indomethacin Capsules 25mgAntipyretic Analgesics Medicines Indomethacin Capsules 25mgAntipyretic Analgesics Medicines Indomethacin Capsules 25mgAntipyretic Analgesics Medicines Indomethacin Capsules 25mg

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier